Sept 13 (Reuters) – GE HealthCare Technologies is in talks over a possible $1 billion deal to buy radiopharmaceutical developer Sofie Biosciences, the Financial Times reported on Sunday citing people
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
JAPAN'S NIKKEI AVERAGE FUTURES DOWN 0.4% IN EARLY TRADE
JAPAN'S NIKKEI AVERAGE FUTURES DOWN 0.4% IN EARLY TRADE (The article has been published through…
Cyberattack concealed political spending by big donors before US midterm elections
By Dawn Kopecki NEW YORK, Oct 28 (Reuters) - The Federal Election Commission restored its…
Fed's policy committee to weigh balance sheet issues early next year, Warsh says
By Michael S. Derby NEW YORK, Oct 28 (Reuters) - Federal Reserve Chairman Kevin Warsh…
